Gastrointestinal Therapeutics-India Market Status and Trend Report 2013-2023
SKU ID :MI-11301950 | Published Date: 01-Apr-2018 | No. of pages: 135Description
TOC
Table of Contents
Chapter 1 Overview of Gastrointestinal Therapeutics
1.1 Definition of Gastrointestinal Therapeutics in This Report
1.2 Commercial Types of Gastrointestinal Therapeutics
1.2.1 Tablets
1.2.2 Injection
1.3 Downstream Application of Gastrointestinal Therapeutics
1.3.1 IBD
1.3.2 Irritable Bowel Syndrome (IBS)
1.3.3 Other
1.4 Development History of Gastrointestinal Therapeutics
1.5 Market Status and Trend of Gastrointestinal Therapeutics 2013-2023
1.5.1 India Gastrointestinal Therapeutics Market Status and Trend 2013-2023
1.5.2 Regional Gastrointestinal Therapeutics Market Status and Trend 2013-2023
Chapter 2 India Market Status and Forecast by Regions
2.1 Market Status of Gastrointestinal Therapeutics in India 2013-2017
2.2 Consumption Market of Gastrointestinal Therapeutics in India by Regions
2.2.1 Consumption Volume of Gastrointestinal Therapeutics in India by Regions
2.2.2 Revenue of Gastrointestinal Therapeutics in India by Regions
2.3 Market Analysis of Gastrointestinal Therapeutics in India by Regions
2.3.1 Market Analysis of Gastrointestinal Therapeutics in North India 2013-2017
2.3.2 Market Analysis of Gastrointestinal Therapeutics in Northeast India 2013-2017
2.3.3 Market Analysis of Gastrointestinal Therapeutics in East India 2013-2017
2.3.4 Market Analysis of Gastrointestinal Therapeutics in South India 2013-2017
2.3.5 Market Analysis of Gastrointestinal Therapeutics in West India 2013-2017
2.4 Market Development Forecast of Gastrointestinal Therapeutics in India 2017-2023
2.4.1 Market Development Forecast of Gastrointestinal Therapeutics in India 2017-2023
2.4.2 Market Development Forecast of Gastrointestinal Therapeutics by Regions 2017-2023
Chapter 3 India Market Status and Forecast by Types
3.1 Whole India Market Status by Types
3.1.1 Consumption Volume of Gastrointestinal Therapeutics in India by Types
3.1.2 Revenue of Gastrointestinal Therapeutics in India by Types
3.2 India Market Status by Types in Major Countries
3.2.1 Market Status by Types in North India
3.2.2 Market Status by Types in Northeast India
3.2.3 Market Status by Types in East India
3.2.4 Market Status by Types in South India
3.2.5 Market Status by Types in West India
3.3 Market Forecast of Gastrointestinal Therapeutics in India by Types
Chapter 4 India Market Status and Forecast by Downstream Industry
4.1 Demand Volume of Gastrointestinal Therapeutics in India by Downstream Industry
4.2 Demand Volume of Gastrointestinal Therapeutics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Gastrointestinal Therapeutics by Downstream Industry in North India
4.2.2 Demand Volume of Gastrointestinal Therapeutics by Downstream Industry in Northeast India
4.2.3 Demand Volume of Gastrointestinal Therapeutics by Downstream Industry in East India
4.2.4 Demand Volume of Gastrointestinal Therapeutics by Downstream Industry in South India
4.2.5 Demand Volume of Gastrointestinal Therapeutics by Downstream Industry in West India
4.3 Market Forecast of Gastrointestinal Therapeutics in India by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Gastrointestinal Therapeutics
5.1 India Economy Situation and Trend Overview
5.2 Gastrointestinal Therapeutics Downstream Industry Situation and Trend Overview
Chapter 6 Gastrointestinal Therapeutics Market Competition Status by Major Players in India
6.1 Sales Volume of Gastrointestinal Therapeutics in India by Major Players
6.2 Revenue of Gastrointestinal Therapeutics in India by Major Players
6.3 Basic Information of Gastrointestinal Therapeutics by Major Players
6.3.1 Headquarters Location and Established Time of Gastrointestinal Therapeutics Major Players
6.3.2 Employees and Revenue Level of Gastrointestinal Therapeutics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
Chapter 7 Gastrointestinal Therapeutics Major Manufacturers Introduction and Market Data
7.1 Johnson & Johnson
7.1.1 Company profile
7.1.2 Representative Gastrointestinal Therapeutics Product
7.1.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.2 AbbVie
7.2.1 Company profile
7.2.2 Representative Gastrointestinal Therapeutics Product
7.2.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of AbbVie
7.3 Allergan
7.3.1 Company profile
7.3.2 Representative Gastrointestinal Therapeutics Product
7.3.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Allergan
7.4 Takeda
7.4.1 Company profile
7.4.2 Representative Gastrointestinal Therapeutics Product
7.4.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Takeda
7.5 Novartis
7.5.1 Company profile
7.5.2 Representative Gastrointestinal Therapeutics Product
7.5.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Novartis
7.6 Pfizer
7.6.1 Company profile
7.6.2 Representative Gastrointestinal Therapeutics Product
7.6.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Pfizer
7.7 GlaxoSmithKline
7.7.1 Company profile
7.7.2 Representative Gastrointestinal Therapeutics Product
7.7.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
7.8 Merck
7.8.1 Company profile
7.8.2 Representative Gastrointestinal Therapeutics Product
7.8.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Merck
7.9 UCB (Belgium)
7.9.1 Company profile
7.9.2 Representative Gastrointestinal Therapeutics Product
7.9.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of UCB (Belgium)
7.10 F. Hoffmann-La Roche
7.10.1 Company profile
7.10.2 Representative Gastrointestinal Therapeutics Product
7.10.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche
7.11 Eli Lilly
7.11.1 Company profile
7.11.2 Representative Gastrointestinal Therapeutics Product
7.11.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Eli Lilly
7.12 AstraZeneca
7.12.1 Company profile
7.12.2 Representative Gastrointestinal Therapeutics Product
7.12.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of AstraZeneca
7.13 Procter & Gamble
7.13.1 Company profile
7.13.2 Representative Gastrointestinal Therapeutics Product
7.13.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Procter & Gamble
7.14 Eisai
7.14.1 Company profile
7.14.2 Representative Gastrointestinal Therapeutics Product
7.14.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Eisai
7.15 Shire Pharmaceuticals
7.15.1 Company profile
7.15.2 Representative Gastrointestinal Therapeutics Product
7.15.3 Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Shire Pharmaceuticals
7.16 Ferring Pharmaceuticals
7.17 Kyowa Hakko Kirin
7.18 Salix Pharmaceuticals
7.19 Ono Pharmaceutical
7.20 TSD Japan
7.21 RedHill Biopharma
7.22 Kaken Pharmaceutical
7.23 Amgen
7.24 Synergy Pharmaceuticals
7.25 Ajinomoto
7.26 Kissei Pharmaceutical
7.27 Hutchison Medi Pharma
Chapter 8 Upstream and Downstream Market Analysis of Gastrointestinal Therapeutics
8.1 Industry Chain of Gastrointestinal Therapeutics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Gastrointestinal Therapeutics
9.1 Cost Structure Analysis of Gastrointestinal Therapeutics
9.2 Raw Materials Cost Analysis of Gastrointestinal Therapeutics
9.3 Labor Cost Analysis of Gastrointestinal Therapeutics
9.4 Manufacturing Expenses Analysis of Gastrointestinal Therapeutics
Chapter 10 Marketing Status Analysis of Gastrointestinal Therapeutics
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
Tables & Figures
List of Tables
Table Advantage and Disadvantage of Tablets
Table Advantage and Disadvantage of Injection
Table Consumption Volume of Gastrointestinal Therapeutics in India by Regions 2013-2017
Table Revenue of Gastrointestinal Therapeutics in India by Regions 2013-2017
Table Consumption Volume of Gastrointestinal Therapeutics in India by Regions 2018-2023
Table Revenue of Gastrointestinal Therapeutics in India by Regions 2018-2023
Table Consumption Volume of Gastrointestinal Therapeutics in India by Types 2013-2017
Table Revenue of Gastrointestinal Therapeutics in India by Types 2013-2017
Table Consumption Volume of Gastrointestinal Therapeutics by Types in North India 2013-2017
Table Consumption Volume of Gastrointestinal Therapeutics by Types in Northeast India 2013-2017
Table Consumption Volume of Gastrointestinal Therapeutics by Types in East India 2013-2017
Table Consumption Volume of Gastrointestinal Therapeutics by Types in South India 2013-2017
Table Consumption Volume of Gastrointestinal Therapeutics by Types in West India 2013-2017
Table Consumption Volume Forecast of Gastrointestinal Therapeutics in India by Types 2018-2023
Table Revenue Forecast of Gastrointestinal Therapeutics in India by Types 2018-2023
Table Demand Volume of Gastrointestinal Therapeutics in India by Downstream Industry 2013-2017
Table Demand Volume of Gastrointestinal Therapeutics by Downstream Industry in North India 2013-2017
Table Demand Volume of Gastrointestinal Therapeutics by Downstream Industry in Northeast India 2013-2017
Table Demand Volume of Gastrointestinal Therapeutics by Downstream Industry in East India 2013-2017
Table Demand Volume of Gastrointestinal Therapeutics by Downstream Industry in South India 2013-2017
Table Demand Volume of Gastrointestinal Therapeutics by Downstream Industry in West India 2013-2017
Table Demand Volume Forecast of Gastrointestinal Therapeutics in India by Downstream Industry 2018-2023
Table Sales Volume of Gastrointestinal Therapeutics in India by Major Players 2013-2017
Table Revenue of Gastrointestinal Therapeutics in India by Major Players 2013-2017
Table Headquarters Location and Established Time of Gastrointestinal Therapeutics Major Players
Table Employees and Revenue Level of Gastrointestinal Therapeutics Major Players
Table Representative Gastrointestinal Therapeutics Product One of Johnson & Johnson
Table Representative Gastrointestinal Therapeutics Product Two of Johnson & Johnson
Table Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Johnson & Johnson 2013-2017
Table Representative Gastrointestinal Therapeutics Product One of AbbVie
Table Representative Gastrointestinal Therapeutics Product Two of AbbVie
Table Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of AbbVie 2013-2017
Table Representative Gastrointestinal Therapeutics Product One of Allergan
Table Representative Gastrointestinal Therapeutics Product Two of Allergan
Table Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Allergan 2013-2017
Table Representative Gastrointestinal Therapeutics Product One of Takeda
Table Representative Gastrointestinal Therapeutics Product Two of Takeda
Table Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Takeda 2013-2017
Table Representative Gastrointestinal Therapeutics Product One of Novartis
Table Representative Gastrointestinal Therapeutics Product Two of Novartis
Table Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Novartis 2013-2017
Table Representative Gastrointestinal Therapeutics Product One of Pfizer
Table Representative Gastrointestinal Therapeutics Product Two of Pfizer
Table Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Pfizer 2013-2017
Table Representative Gastrointestinal Therapeutics Product One of GlaxoSmithKline
Table Representative Gastrointestinal Therapeutics Product Two of GlaxoSmithKline
Table Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of GlaxoSmithKline 2013-2017
Table Representative Gastrointestinal Therapeutics Product One of Merck
Table Representative Gastrointestinal Therapeutics Product Two of Merck
Table Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Merck 2013-2017
Table Representative Gastrointestinal Therapeutics Product One of UCB (Belgium)
Table Representative Gastrointestinal Therapeutics Product Two of UCB (Belgium)
Table Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of UCB (Belgium) 2013-2017
Table Representative Gastrointestinal Therapeutics Product One of F. Hoffmann-La Roche
Table Representative Gastrointestinal Therapeutics Product Two of F. Hoffmann-La Roche
Table Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche 2013-2017
Table Representative Gastrointestinal Therapeutics Product One of Eli Lilly
Table Representative Gastrointestinal Therapeutics Product Two of Eli Lilly
Table Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Eli Lilly 2013-2017
Table Representative Gastrointestinal Therapeutics Product One of AstraZeneca
Table Representative Gastrointestinal Therapeutics Product Two of AstraZeneca
Table Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of AstraZeneca 2013-2017
Table Representative Gastrointestinal Therapeutics Product One of Procter & Gamble
Table Representative Gastrointestinal Therapeutics Product Two of Procter & Gamble
Table Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Procter & Gamble 2013-2017
Table Representative Gastrointestinal Therapeutics Product One of Eisai
Table Representative Gastrointestinal Therapeutics Product Two of Eisai
Table Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Eisai 2013-2017
Table Representative Gastrointestinal Therapeutics Product One of Shire Pharmaceuticals
Table Representative Gastrointestinal Therapeutics Product Two of Shire Pharmaceuticals
Table Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin of Shire Pharmaceuticals 2013-2017
Companies
- PRICE
-
$2980$5680